Drugs / Hyruan
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT05220527 Background | Aug 2020 → Jul 2022 | osteoarthritis, knee | Taipei Medical University | Unknown | No outcome recorded |
| — | NCT07646483 Comparator | Jun 2026 → Sep 2027 expected | osteoarthritis, knee | PharmaResearch | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hyruan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05220527 ↗ |